지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Changes in bone mineral density and trabecular bone score in Graves’ disease patients after anti-thyroid therapy
Osteoporosis and Sarcopenia
2016 .01
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
Clinical and Molecular Hepatology
2024 .07
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study
Clinical and Molecular Hepatology
2024 .04
Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression
Clinical and Molecular Hepatology
2024 .04
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
Clinical and Molecular Hepatology
2024 .07
Usefulness of Rigid Bronchoscopic Intervention Using Argon Plasma Coagulation for Central Airway Tumors
Clinical and Experimental Otorhinolaryngology
2015 .01
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Clinical and Molecular Hepatology
2023 .02
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
Diabetes and Metabolism Journal
2022 .07
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
Clinical and Molecular Hepatology
2024 .04
Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD
Clinical and Molecular Hepatology
2024 .01
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Clinical and Molecular Hepatology
2023 .04
Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms
Journal of Obesity & Metabolic Syndrome
2024 .06
Effect of Korean Red Ginseng in chronic liver disease
Journal of Ginseng Research
2017 .10
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2021 .01
Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Clinical and Molecular Hepatology
2024 .04
Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
Clinical and Molecular Hepatology
2024 .04
No More NAFLD: The Term Is Now MASLD
Endocrinology and Metabolism
2024 .02
0